Ravi P Anantha

USPTO Granted Patents = 8 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 4.7

ph-index = 1

Location History:

Rockville, MD (US) (2019 - 2023)
New York, NY (US) (2021 - 2023)

Company Filing History:

7 out of 68

International Aids Vaccine Initiative

patents

3 out of 504

Oregon Health & Science University

patents

1 out of 1

International Aids Vaccine Initative, Inc.

patent

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12442018 - Recombinant cytomegalovirus vectors as vaccines for tuberculosis (2025-10-14),

2. 11834669 - Recombinant cytomegalovirus vectors as vaccines for tuberculosis (2023-12-05),

3. 11787842 - Tuberculosis compositions and methods of using the same (2023-10-17),

4. 11692014 - Tuberculosis compositions and methods of treating or preventing tuberculosis (2023-07-04),

5. 11091775 - Recombinant cytomegalovirus vectors as vaccines for tuberculosis (2021-08-17),

6. 11014969 - Tuberculosis compositions and methods of using the same (2021-05-25),

7. 10428122 - Tuberculosis compositions and methods of treating or preventing tuberculosis (2019-10-01),

8. 10266574 - Tuberculosis compositions and methods of using the same (2019-04-23),

Title: Innovations of Ravi P Anantha

Introduction

Ravi P Anantha is a notable inventor based in Rockville, MD, with a significant contribution to the field of biotechnology. He holds a total of 8 patents, showcasing his innovative approach to developing solutions in medical science.

Latest Patents

Among his latest patents are the recombinant cytomegalovirus vectors designed as vaccines for tuberculosis. These patents provide cytomegalovirus vectors encoding fusion proteins that comprise Mycobacterium tuberculosis (Mtb) antigens. They also include nucleic acid molecules encoding the same, cytomegalovirus vectors comprising these nucleic acid molecules, and compositions that include them. Furthermore, the patents detail methods for eliciting an immune response against tuberculosis.

Career Highlights

Ravi has worked with prominent organizations such as the International Aids Vaccine Initiative and Oregon Health & Science University. His work in these institutions has significantly advanced research in vaccine development and infectious diseases.

Collaborations

Some of his notable coworkers include Thomas G Evans and Aurelio M Bonavia, who have collaborated with him on various projects.

Conclusion

Ravi P Anantha's contributions to the field of biotechnology, particularly in vaccine development, highlight his role as an influential inventor. His innovative patents and collaborations continue to impact the fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.